Analyst Price Targets — PBH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 30, 2026 5:48 pm | Keith Devas | Jefferies | $66.00 | $64.18 | TheFly | Prestige Consumer price target lowered to $66 from $70 at Jefferies |
| October 27, 2025 11:40 am | — | Jefferies | $71.00 | $61.96 | TheFly | Prestige Consumer price target lowered to $71 from $75 at Jefferies |
| November 5, 2024 12:26 pm | SUsan Anderson | Canaccord Genuity | $86.00 | $74.58 | StreetInsider | Presitge Brands (PBH) PT Raised to $86 at Canaccord Genuity |
| June 21, 2024 6:15 am | Linda Bolton Weiser | D.A. Davidson | $93.00 | $68.13 | StreetInsider | DA Davidson Defending Presitge Brands (PBH), Uprades to Buy |
| November 17, 2022 6:06 am | — | Canaccord Genuity | $71.00 | $58.35 | Benzinga | Canaccord Genuity Initiates Coverage On Prestige Consumer with Buy Rating, Announces Price Target of $71 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for PBH

Bleakley Financial Group LLC purchased a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,912 shares of the company's stock, valued at approximately $681,000. Several other hedge funds and

/PRNewswire/ -- Equity-Insider.com News Commentary - The global health and wellness sector is entering 2026 on a trajectory toward $6 trillion in annual

One profitable company whose shares we've held for years, and that demonstrates why a focus on shareholder value creation matters in the long run, is Old Republic International. A new mid-cap holding in the quarter was Prestige Consumer Healthcare, whose over-the-counter brands are familiar to many. A multi-year holding that has struggled recently is Watsco, the largest wholesale distributor of HVAC and…

Prestige Consumer Healthcare Inc. (NYSE: PBH - Get Free Report) has earned a consensus recommendation of "Hold" from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price

Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for PBH.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
